Fredag 27 December | 08:22:21 Europe / Stockholm
Svenska | English

Surgical Science Sweden AB (publ)

Bifogade filer

Kursutveckling under dagen för detta pressmeddelande (SEK).

Likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

Tid*
2026-02-19 07:30 Bokslutskommuniké 2025
2025-11-13 07:30 Kvartalsrapport 2025-Q3
2025-08-21 07:30 Kvartalsrapport 2025-Q2
2025-05-14 07:30 Kvartalsrapport 2025-Q1
2025-02-19 07:30 Bokslutskommuniké 2024
2024-11-14 - Kvartalsrapport 2024-Q3
2024-08-22 - Kvartalsrapport 2024-Q2
2024-05-17 - X-dag ordinarie utdelning SUS 0.00 SEK
2024-05-16 - Årsstämma
2024-05-15 - Kvartalsrapport 2024-Q1
2024-02-21 - Bokslutskommuniké 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-19 - X-dag ordinarie utdelning SUS 0.00 SEK
2023-05-17 - Årsstämma
2023-05-16 - Kvartalsrapport 2023-Q1
2023-02-22 - Bokslutskommuniké 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-13 - X-dag ordinarie utdelning SUS 0.00 SEK
2022-05-12 - Årsstämma
2022-05-11 - Kvartalsrapport 2022-Q1
2022-02-16 - Bokslutskommuniké 2021
2021-11-10 - Kvartalsrapport 2021-Q3
2021-08-20 - Kvartalsrapport 2021-Q2
2021-08-16 - Extra Bolagsstämma 2021
2021-05-14 - X-dag ordinarie utdelning SUS 0.00 SEK
2021-05-12 - Årsstämma
2021-05-11 - Kvartalsrapport 2021-Q1
2021-02-11 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-25 - Split SUS 1:5
2020-05-07 - X-dag ordinarie utdelning SUS 0.00 SEK
2020-05-06 - Årsstämma
2020-05-05 - Kvartalsrapport 2020-Q1
2020-02-07 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-08-23 - Kvartalsrapport 2019-Q2
2019-07-17 - Extra Bolagsstämma 2019
2019-05-10 - X-dag ordinarie utdelning SUS 0.00 SEK
2019-05-09 - Årsstämma
2019-05-08 - Kvartalsrapport 2019-Q1
2019-02-22 - Bokslutskommuniké 2018
2018-11-21 - Kvartalsrapport 2018-Q3
2018-08-24 - Kvartalsrapport 2018-Q2
2018-05-23 - X-dag ordinarie utdelning SUS 0.00 SEK
2018-05-22 - Årsstämma
2018-05-22 - Kvartalsrapport 2018-Q1
2018-02-22 - Bokslutskommuniké 2017
2017-11-22 - Kvartalsrapport 2017-Q3
2017-08-17 - Kvartalsrapport 2017-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Surgical Science Sweden är verksamt inom medicinteknik. Bolaget utvecklar VR-simulatorer inom kirurgin. Simulatorerna består både hård- och mjukvara som används i träning och personlig utveckling hos kirurger. Hårdvaran simulerar diverse kirurgiska ingrepp, med främst användning inom titthålskirurgi samt endoskopi. Visionen är att stärka kompetensen inom kirurgin samt skapa förutsättningar för bättre behandlingar. Bolaget har sitt huvudkontor i Göteborg.
Nomination Committee of Surgical Science Sweden AB (publ)
2023-10-24 08:30:00

The following members have been appointed to Surgical Sciences' Nomination Committee for the 2024 Annual General Meeting:

Åsa Hedin, appointed by Marknadspotential AB
Celia Grip, appointed by Swedbank Robur Fonder
Anna Sundberg, appointed by Handelsbanken Fonder
Roland Bengtsson, Chairman of the Board

The appointments have been made in accordance with the instructions regarding principles for the appointment of the company’s Nomination Committee established at the Annual General Meeting of Surgical Science on May 6, 2020. The shareholders that have appointed the members of the Nomination Committee represented in aggregate just above 27 percent of all shares in the company as of September 30, 2023.

The Nomination Committee shall prepare and submit proposals to the Annual General Meeting regarding: (i) election of Chairman of the Meeting, (ii) election of board members, (iii) election of Chairman of the Board, (iv) resolution on board remuneration with the division between the chairman and other members of the board, (v) resolution on remuneration for the members of the Remuneration and Audit Committee (if applicable), (vi) election of auditors, (vii) resolution on remuneration of auditors, and (viii) to the extent deemed necessary, resolution on amendments in current rules for the Nomination Committee.

The Annual General Meeting of Surgical Science Sweden AB (publ) will be held on Thursday, May 16, 2024 in Gothenburg. Shareholders who wish to submit proposals to the Nomination Committee are welcome to do so in due time before the 2024 Annual General Meeting so that the Nomination Committee has time to consider the proposal. Proposals may be sent to Surgical Science Sweden AB (publ), Att: Nomination Committee, Drakegatan 7A, 412 50 Gothenburg, Sweden.

Gothenburg, Sweden, October 24, 2023
Surgical Science Sweden AB (publ)

The press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/aktien/pressmeddelanden/
 
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

For further information, please contact:

Gisli Hennermark, CEO
Telephone: +46-70-420 83 00
E-mail: gisli.hennermark@surgicalscience.com

Anna Ahlberg, CFO
Telephone: +46-70-855 38 35
E-mail: anna.ahlberg@surgicalscience.com

About Surgical Science Sweden AB (publ)

One of the biggest challenges within healthcare globally is reducing injuries incurred during care. Medical education and training are key, especially as a large part of the training can now be performed outside the operating room. Surgical Science is a world leader in the development of virtual reality simulators for evidence-based training. The simulators enable surgeons and other medical specialists to train and improve their psycho-motor skills and instrument handling before entering the clinical environment. Alongside its own products, Surgical Science works with simulation solutions for medical device companies that develop instruments for clinical use, such as robotic surgery.

Surgical Science has approximately 260 employees. The company is headquartered in Gothenburg, Sweden and also has operations in Tel Aviv, Israel, as well as in Stockholm, Sweden and in Seattle and Cleveland, US. Through sales offices in the US and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank.

Attachments

Nomination Committee of Surgical Science Sweden AB (publ)

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden